Published in J Immunol on November 15, 2001
Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest (2010) 1.55
Tregs and transplantation tolerance. J Clin Invest (2004) 1.49
CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol (2011) 1.45
Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb Perspect Med (2013) 1.29
Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant (2011) 1.18
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest (2002) 1.12
NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity. J Immunol (2010) 1.04
Donor dendritic cell-derived exosomes promote allograft-targeting immune response. J Clin Invest (2016) 1.03
Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant (2008) 1.02
Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II. J Immunol (2008) 1.01
Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs. Am J Transplant (2012) 1.01
Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism. J Clin Invest (2003) 0.99
Recent progress and new perspectives in studying T cell responses to allografts. Am J Transplant (2010) 0.96
Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation. Transpl Int (2007) 0.92
Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol (2012) 0.91
Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles. Front Immunol (2014) 0.88
Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation. Front Immunol (2015) 0.87
NK cells: elusive participants in transplantation immunity and tolerance. Curr Opin Immunol (2010) 0.86
Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation. Transplantation (2009) 0.84
Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis. J Immunol (2013) 0.82
Costimulation blockade inhibits the indirect pathway of allorecognition in nerve allograft rejection. Muscle Nerve (2011) 0.78
Tolerance-inducing strategies in transplantation surgery-current status and perspectives. Langenbecks Arch Surg (2003) 0.77
Cell therapy to induce allograft tolerance: time to switch to plan B? Front Immunol (2015) 0.77
Effect of cold nerve allograft preservation on antigen presentation and rejection. J Neurosurg (2010) 0.77
The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts. Am J Transplant (2009) 0.77
Rapid dendritic cell activation and resistance to allotolerance induction in anti-CD154-treated mice receiving CD47-deficient donor-specific transfusion. Cell Transplant (2013) 0.75
The Limits of Linked Suppression for Regulatory T Cells. Front Immunol (2016) 0.75
Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med (2001) 3.47
Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol (2001) 2.93
Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med (1998) 2.43
Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A (1996) 2.40
NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity (2001) 2.38
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest (2001) 2.19
Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci U S A (1993) 2.18
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16
Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med (1997) 2.07
CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol (2001) 1.79
Missed neuroleptic malignant syndrome. BMJ (1992) 1.79
Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity (2000) 1.74
The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant (2012) 1.73
Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med (1998) 1.65
Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J Immunol (1988) 1.63
Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am J Transplant (2012) 1.61
Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.61
CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int (1997) 1.57
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51
Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49
Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci U S A (2001) 1.48
Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med (1996) 1.48
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45
Membranous nephropathy in a patient with renal cell carcinoma. Am J Kidney Dis (1991) 1.42
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest (1997) 1.42
Costimulation and autoimmune diabetes in BB rats. Am J Transplant (2006) 1.41
In vivo use of monoclonal antibodies against murine T cell antigens. Clin Immunol Immunopathol (1989) 1.41
Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. Transplantation (1996) 1.38
Immunosuppressive strategies in transplantation. Lancet (1999) 1.38
Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med (1992) 1.37
Role of the PD-1 pathway in the immune response. Am J Transplant (2012) 1.35
Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol (1998) 1.33
Two levels of help for B cell alloantibody production. J Exp Med (1996) 1.31
Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse. J Exp Med (1990) 1.26
Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation (1995) 1.25
CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol (1995) 1.25
Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today (1999) 1.25
B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4. J Clin Invest (2001) 1.24
Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest (1996) 1.24
Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med (1994) 1.24
Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis (2006) 1.23
CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest (2000) 1.22
Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation (1998) 1.22
The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg (1992) 1.22
Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation (1999) 1.20
The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest (2000) 1.19
Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway. Infect Immun (2000) 1.17
CD28-independent costimulation of T cells in alloimmune responses. J Immunol (2001) 1.16
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation (1992) 1.16
Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant (2007) 1.16
The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J Immunol (1999) 1.16
Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect Immun (1999) 1.15
Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med (1984) 1.14
Liver transplantation for primary hepatic cancer. Transplantation (1992) 1.13
Two distinct murine differentiation antigens determined by genes linked to the Ly-6 locus. J Immunol (1981) 1.11
Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest (2001) 1.11
Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation (1997) 1.10
Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med (1995) 1.10
CD28-independent induction of experimental autoimmune encephalomyelitis. J Clin Invest (2001) 1.10
A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation (1993) 1.10
CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol (1994) 1.09
CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol (1999) 1.08
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation (1997) 1.07
Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J Immunol (2001) 1.07
MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice. Int Immunol (1995) 1.07
Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med (1989) 1.07
Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro. J Immunol (2001) 1.06
Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int (1999) 1.06
T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction. J Am Soc Nephrol (1995) 1.06
Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation (1995) 1.05
Osteochondroma of Chest Wall. Ann Surg (1934) 1.05
The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis). Am J Transplant (2003) 1.03
Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol (2001) 1.03
Dyslipidemia and its therapeutic challenges in renal transplantation. Am J Transplant (2012) 1.03
Challenges to achieving clinical transplantation tolerance. J Clin Invest (2001) 1.03
The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin. J Infect Dis (1999) 1.02
The role of donor and recipient B7-1 (CD80) in allograft rejection. J Immunol (1997) 1.02
CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. J Immunol (1997) 1.02
CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo. Transplantation (1996) 1.01
Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J Exp Med (1993) 1.01
Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant (2001) 1.00
Endothelin in organ transplantation. Am J Kidney Dis (1996) 0.99